Paraquat Lawsuit | Parkinson’s Disease Attorneys

December 9, 2024

The U.S. District Court overseeing the Paraquat Lawsuit will hold a status conference on December 19, 2024, to evaluate litigation progress and review case summaries for the next round of bellwether trials.

The lawsuits, consolidated into an MDL in the Southern District of Illinois under Judge Nancy J. Rosenstengel, allege that Syngenta and Chevron failed to warn users of Paraquat’s link to Parkinson’s disease, with over 5,800 cases currently pending.

After an earlier round of bellwether cases was dismissed due to excluded expert testimony, the court selected 10 new cases for discovery in August 2024, relying on different expert witnesses.

Lawyers submitted summaries by December 16 outlining key issues and evidence, which will be reviewed during the conference along with updates on discovery progress.

The December 19 status conference will cover the following:

• Review of the recently submitted summaries for the selected bellwether cases.
• Updates on the progress of discovery for the 10 cases under review.
• Discussion of potential scheduling for the first Paraquat bellwether trial, though trial dates remain unconfirmed.

The court may also discuss scheduling the first bellwether trial, which will test jury responses to evidence and potentially shape settlement discussions.

If no settlement occurs, cases may return to their original courts for individual trials.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

December 3, 2024

The Environmental Working Group (EWG) has renewed its plea for the Biden administration to ban Paraquat, a widely used herbicide that has been linked to an increased risk of Parkinson’s disease.

Although Paraquat is already prohibited in over 70 countries, it remains in use in the U.S., posing significant health risks to farmworkers and rural communities.

This has fueled growing demands for swift regulatory action.

Advocates argue that banning Paraquat would strengthen President Biden’s chemical safety legacy, complementing prior measures taken against PFAS, asbestos, and chlorpyrifos. Mounting scientific evidence highlights the connection between Paraquat exposure and serious health issues, underscoring the urgency for the U.S. to adopt stricter safety standards in line with global practices.

The EPA is under increasing pressure to act decisively, as the ongoing use of Paraquat raises critical concerns about protecting public health and safeguarding vulnerable populations.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

December 2, 2024

The Paraquat Lawsuit is ongoing. 

The Judicial Panel on Multidistrict Litigation (JPML) reported 5,818 case filings in the Paraquat lawsuit as of November, increasing to 5,835 in December, with 17 new cases added.

The lawsuit alleges that exposure to the herbicide Paraquat is linked to Parkinson’s disease and other serious health conditions.

This growth in filings may stem from increased awareness, recent medical studies, or attorneys identifying additional eligible claimants.

The Paraquat multidistrict litigation continues to grow as new plaintiffs accuse manufacturers of failing to warn about the product’s risks.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

November 12, 2024

The Paraquat Lawsuit is ongoing. 

The Paraquat MDL has seen progress despite initial setbacks, including the exclusion of the Plaintiffs’ general causation expert, which initially slowed the case.

However, the MDL Judge has now moved forward by selecting 10 new bellwether cases for discovery, initially chosen in August 2024.

Following the voluntary dismissal of two cases, substitute cases were introduced, and discovery efforts are actively underway.

Parallel developments are occurring in Philadelphia, where cases are advancing with the exchange of expert reports.

Important deadlines include motions for summary judgment and expert exclusions, both due by December 4, 2024.

Oral arguments are expected in early 2025, with a trial scheduled for April 2025.

With the Philadelphia trial date approaching, this case could set a pivotal precedent, showcasing whether Plaintiffs can successfully counter the Defendants’ challenges and proceed to trial.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

November 8, 2024

The Paraquat Lawsuit is ongoing. 

Over 50 U.S. lawmakers are urging the Environmental Protection Agency (EPA) to ban paraquat, a widely used herbicide linked to serious health and environmental risks.

In an October 31 letter, seven U.S. senators described paraquat as “highly toxic” and called its continued use unjustifiable due to the potential harm it poses to farmworkers and rural communities.

This appeal follows a similar request from 47 members of the U.S. House of Representatives, all pushing for the EPA to take definitive action.

Lawmakers pointed to mounting scientific research that links paraquat exposure to severe health issues, especially Parkinson’s disease.

Studies indicate that exposure to paraquat can increase the risk of Parkinson’s by up to 64%, along with other life-threatening diseases such as non-Hodgkin’s lymphoma and thyroid cancer.

The EPA has previously stated there is no “clear link” between paraquat and Parkinson’s, though it recognizes the herbicide’s acute toxicity and has introduced certain restrictions on its application.

In a draft report issued in 2024, the EPA reaffirmed this stance, committing to a comprehensive review of additional studies with a final report expected by January 2025.

Pressure is growing from both federal and state leaders, and the EPA’s final decision on paraquat is anticipated in early 2025 as it continues evaluating the latest evidence on the herbicide’s risks.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

November 5, 2024

The Paraquat Lawsuit is ongoing. 

Ten cases have recently been selected for case-specific discovery to prepare for upcoming trials.

This discovery phase involves an exchange of documents and essential information, including written responses, medical records, and professional records.

Additionally, the discovery process includes depositions of plaintiffs, witnesses attesting to each plaintiff’s Paraquat exposure, damages witnesses detailing the impact of Parkinson’s disease, and treating healthcare providers.

In December, the court is set to narrow this group further, choosing cases for additional expert reports and testimony, which will set the stage for future trials.

Earlier this year, the court excluded the Plaintiffs’ primary causation experts, resulting in the dismissal of four cases—a decision currently under appeal.

Meanwhile, Plaintiffs have developed new expert witnesses to provide testimony in upcoming trials.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

November 1, 2024

The Paraquat Parkinson’s Disease lawsuit involves claims that exposure to the herbicide Paraquat is linked to an elevated risk of Parkinson’s disease and other severe health issues.

Plaintiffs allege that manufacturers failed to adequately warn users, especially agricultural workers, of the dangers associated with prolonged exposure to Paraquat.

In October, the Paraquat lawsuit saw 5,883 cases filed, but this number slightly decreased to 5,818 in November, reflecting a reduction of 65 cases.

This decline may result from case consolidations or other procedural adjustments as the litigation moves forward.

Paraquat exposure has been connected to neurotoxic effects, contributing to Parkinson’s disease, which can severely affect a person’s mobility, quality of life, and long-term health.

If you or a loved one has been exposed to paraquat and developed serious health issues like Parkinson’s disease, you may be eligible to file a Paraquat Lawsuit. 

Contact TruLaw for a free consultation to discuss your legal options with a Paraquat Lawyer.

You can also use our chatbot on this page to see if you qualify for the Paraquat Lawsuit with an instant online case evaluation.

October 9, 2024

The Paraquat Herbicide Litigation is ongoing. 

A group of 47 members of Congress, led by Rep. Greg Casar from Texas, is pushing for the U.S. Environmental Protection Agency (EPA) to ban the herbicide paraquat due to its significant risks to human health and the environment.

In a letter sent to EPA Administrator Michael S. Regan, the lawmakers highlighted paraquat’s link to severe health conditions, including Parkinson’s disease, non-Hodgkin’s lymphoma, and thyroid cancer.

The letter also pointed out paraquat’s long-term impact on the environment, noting its persistence in soil and water, where it can remain for years before breaking down.

Lawmakers are urging the EPA to take action, pointing to the more than 70 countries—such as China, Brazil, Canada, and the European Union—that have already banned or phased out paraquat.

This push for a ban comes as paraquat is the subject of ongoing multidistrict litigation in Illinois federal court.

Geoff Horsfield, policy director for the Environmental Working Group, also expressed support for the ban, emphasizing that safer alternatives are available and that paraquat poses unnecessary risks to farmers and farmworkers.

“Seventy countries have banned paraquat, so we know that farmers have plenty of safer options,” Horsfield stated.

If you or a loved one has been exposed to paraquat and developed serious health issues like Parkinson’s disease, you may be eligible to file a Paraquat Lawsuit. 

Contact TruLaw for a free consultation to discuss your legal options with a Paraquat Lawyer.

You can also use our chatbot on this page to see if you qualify for the Paraquat Lawsuit with an instant online case evaluation.

October 7, 2024

The Paraquat Herbicide Litigation is ongoing. 

In a significant move, California has advanced efforts to address the dangers of paraquat, a toxic herbicide linked to severe health issues like Parkinson’s disease and cancer.

Governor Gavin Newsom recently signed Assembly Bill 1963, mandating the state’s Department of Pesticide Regulation (DPR) to expedite its review of Paraquat.

This prioritized reevaluation must be completed by January 1, 2029, potentially resulting in a ban or stricter regulations on the herbicide.

This legislative action aligns with broader efforts led by advocacy groups such as the Environmental Working Group (EWG) and The Michael J. Fox Foundation, both of which are urging the U.S. Environmental Protection Agency (EPA) to ban paraquat nationwide.

Over 70 countries, including the European Union and China, have already banned the chemical due to its known health risks.

Additionally, Governor Newsom signed Assembly Bill 2113, providing the DPR with enhanced resources to expedite scientific evaluations of toxic pesticides.

The increased registration and sales fees highlight California’s dedication to regulating harmful agricultural chemicals.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

October 1, 2024

The Paraquat litigation, involving claims that exposure to the herbicide causes Parkinson’s disease, remains highly active.

Paraquat, a widely used agricultural chemical, has been linked to serious health risks, including neurological damage.

The lawsuits allege that manufacturers failed to warn consumers about these dangers.

In September, 5,891 Paraquat lawsuits were pending under the Judicial Panel on Multidistrict Litigation (JPML).

By October, that number slightly decreased to 5,883, reflecting a drop of 8 cases.

Despite this decrease, the high volume of lawsuits indicates ongoing concerns about the harmful effects of Paraquat exposure.

Farmers, agricultural workers, and individuals living near treated areas face particularly high risks from exposure to this dangerous chemical.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

September 20, 2024

Paraquat, a herbicide linked to Parkinson’s disease, continues to be a focal point in ongoing legal and regulatory discussions.

As the California State Assembly concluded its 2024 legislative session, a proposed bill to ban paraquat was amended, requiring the California Department of Pesticide Regulation to expedite a review by January 1, 2029.

Meanwhile, public health and environmental advocates are calling for an emergency suspension of paraquat, similar to the recent U.S. Environmental Protection Agency (EPA) ban on Dacthal.

Scientific research has consistently shown the serious health risks associated with paraquat exposure.

A 2020 study highlighted an increased risk of Parkinson’s disease tied to paraquat, with data mapping high-risk areas by zip code.

In addition, a 2019 meta-analysis confirmed that cumulative exposure to paraquat significantly raises the risk of developing Parkinson’s.

The EPA is currently reviewing paraquat following a lawsuit filed by Earthjustice, with a final report expected in 2025.

In legal proceedings, the Paraquat multidistrict litigation (MDL) is advancing. 

The court has set key deadlines, with plaintiffs required to file their omnibus response to the defendants’ motion to dismiss by November 11, 2024, and defendants set to file their reply by December 2, 2024.

Individual plaintiffs may also respond by that date.

On September 17, 2024, the Michael J. Fox Foundation led a national Day of Action, urging the public to call on Congress to pressure the EPA to cancel paraquat’s registration ahead of the 2025 deadline.

Public health advocates and farmworkers continue to push for an outright ban on paraquat in the U.S., where it remains in use despite being banned in over 70 countries.

The EPA is expected to decide on paraquat’s license renewal by January 2025.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

September 3, 2024

A recent study published in Ecotoxicology and Environmental Safety adds to the growing evidence that exposure to the herbicide Paraquat may lead to Parkinson’s disease.

Researchers from Ningxia Medical University School of Public Health conducted tests on human neuroblastoma cell lines, discovering that Paraquat exposure resulted in the buildup of α-synuclein (α-syn), a protein linked to neurodegenerative diseases like Parkinson’s.

They noted that the brain’s reduced ability to clear amyloid proteins is a known contributor to these diseases.

This research further supports claims made in thousands of lawsuits currently pending in U.S. courts, asserting that Paraquat exposure causes Parkinson’s disease.

The Paraquat Products Liability Litigation has seen continued growth, with the number of active cases rising from 5,757 in August 2024 to 5,891 by September 2024. 

This increase reflects greater awareness among potential plaintiffs regarding the alleged risks associated with Paraquat exposure.

The lawsuits, centralized in multidistrict litigation (MDL) under U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois, claim that agricultural workers, farmers, and landscapers exposed to Paraquat developed Parkinson’s due to insufficient warnings about the herbicide’s neurological dangers.

The court has implemented a “bellwether” process, selecting a small number of representative cases for trial to assess how juries might respond to the evidence presented in the larger litigation.

If you or a loved one has been affected by Paraquat exposure, contact TruLaw for a free consultation to discuss your legal options with a Paraquat Lawyer.

Want to find out if you qualify for the Paraquat Lawsuit right away?

August 29, 2024

An Illinois federal judge ruled to keep several cases in the ongoing multidistrict litigation (MDL) involving the herbicide Paraquat, despite the plaintiffs’ counsel missing deadlines to submit required questionnaires.

The judge acknowledged that the delays were caused by the attorney being left as the sole practitioner at his firm following the departure of other attorneys, allowing the cases to move forward.

If you or a loved one has been affected by Paraquat exposure, contact TruLaw for a free consultation to discuss your legal options with a Paraquat Lawyer.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use the chatbot on this page to receive a free instant online case evaluation now.

August 7 ,2024

The Paraquat Lawsuit is ongoing, with bellwether trials selected for the MDL.

In a significant development for the Paraquat multidistrict litigation (MDL), the Judge has recently selected ten new cases to serve as bellwether trials.

This decision follows a major setback in April when all previously selected cases were dismissed, causing delays as parties had spent over a year preparing these cases for trial.

The newly selected bellwether cases will now undergo case-specific fact discovery over the coming months in preparation for potential jury trials.

This process is crucial in advancing the litigation and may set important precedents for future cases.

Despite this progress, there is strong speculation that a global settlement may be reached before any of these bellwether trials begin.

The selection and preparation of these cases put added pressure on the defendants, potentially encouraging settlement negotiations.

If you or a loved one has been affected by Paraquat exposure, contact TruLaw for a free consultation to discuss your legal options with a Paraquat Lawyer.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use the chatbot on this page to receive a free instant online case evaluation now.

August 1, 2024

The Paraquat lawsuit is ongoing. 

The Paraquat Lawsuit involves claims against the manufacturers of Paraquat, a commonly used

herbicide.

Plaintiffs assert that exposure to Paraquat raises the risk of developing Parkinson’s disease.

In July, there were 5,770 filings in the Paraquat Herbicide lawsuit, which slightly decreased to 5,757 by August.

Due to the severe health issues associated with Paraquat exposure, many affected individuals have filed lawsuits against its manufacturers.

If you or a loved one has been affected by Paraquat, contact TruLaw for a free consultation. 

You can also use the chatbot on this page to see if you qualify instantly.

The Paraquat lawsuit is ongoing. 

A comprehensive study published in Frontiers in Cancer Control and Society has identified a significant link between agricultural pesticide use and an increased risk of various cancers.

The study analyzed county-level data to examine pesticide usage patterns and their correlation with cancer incidence.

It found strong associations between pesticide exposure and cancers such as leukemia, non-Hodgkin’s lymphoma, bladder, colon, lung, and pancreatic cancers.

Pesticides like Glyphosate, Atrazine, Boscalid, and Dicamba were associated with higher incidences of these cancers.

Additionally, Paraquat has been under scrutiny for its potential health risks, including a link to Parkinson’s disease.

Numerous lawsuits have been filed against Paraquat manufacturers, with plaintiffs claiming that exposure to the herbicide led to their Parkinson’s disease diagnoses.

If you or a loved one has been affected by Paraquat, contact TruLaw for a free consultation. 

You can also use the chatbot on this page to see if you qualify instantly.

July 1, 2024

The Paraquat lawsuit is ongoing. 

The Paraquat Parkinson’s lawsuit claims that exposure to the herbicide Paraquat is linked to Parkinson’s disease.

In June, there were 5,680 Paraquat Parkinson’s lawsuit filings.

By July, this number increased to 5,770, reflecting growing awareness of Paraquat’s dangers.

Paraquat exposure damages neurons that produce dopamine, leading to Parkinson’s disease symptoms like tremors and impaired movement.

These health impacts have prompted more individuals to join the Paraquat Parkinson’s lawsuit.

The Paraquat Parkinson’s lawsuit aims to hold manufacturers responsible for the harm caused by the herbicide.

If you or a loved one has been affected by Paraquat, contact TruLaw for a free consultation. 

You can also use the chatbot on this page to see if you qualify instantly.

June 26, 2024

The court conducted hearings on Daubert motions, a critical phase where the validity of expert witness testimonies from both parties was scrutinized.

These motions determine the admissibility of scientific evidence in trials.

The court excluded the primary causation expert witness for the plaintiffs, leading to the dismissal of four cases scheduled for trial.

This ruling impacts only those specific cases, and an appeal is being prepared to challenge it.

The court is progressing the Paraquat cases by scheduling additional trials. Both plaintiffs’ and defendants’ legal teams have been instructed to identify cases that can move forward toward trial settings.

Our team is gathering further evidence and working with new experts to bolster the cases. We continue to collect necessary documents, including medical records, to support each client’s situation comprehensively.

We encourage all our clients to remain engaged and responsive to any requests for information. Your cooperation is vital for us to advocate effectively on your behalf.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

June 3, 2024

The Paraquat Lawsuit is ongoing and our Paraquat Herbicide lawyers continue to accept new cases. 

The Paraquat lawsuit centers on the significant health risks allegedly linked to Paraquat, a herbicide extensively used and known for its potent toxicity.

There has been a minor increase in Paraquat case filings, with numbers rising from 5,590 in May to 5,680 in June.

Paraquat is associated with severe health complications, including Parkinson’s disease, primarily due to its high toxicity levels.

The substance is highly poisonous if ingested and can also cause serious lung damage and other respiratory issues upon exposure.

Research consistently highlights the acute toxicity of Paraquat and the risks of chronic health conditions following prolonged exposure.

Our experienced Paraquat lawyers are ready to advise on seeking compensation for medical costs, lost wages, and other damages.

If you or a loved one has subsequently been diagnosed with Parkinson’s Disease after exposure to the herbicide, you may be entitled to recover money for pain and suffering, medical expenses, and lost wages.

You can speak with our virtual assistant by clicking on the chat icon found at the bottom right hand of the page.

May 29, 2024

The Paraquat litigation continues to evolve.

Recent updates have emerged in the lawsuit concerning the safety of Paraquat, a pesticide associated with significant health risks, such as Parkinson’s disease.

The California State Assembly recently voted to pass Assembly Bill 1963, which seeks to ban Paraquat in agricultural applications effective January 1, 2026.

Should this legislation pass, California would become the first state to prohibit the use of Paraquat.

The Environmental Working Group (EWG) endorses the bill, noting that over 60 countries have already banned Paraquat due to its harmful effects.

EWG’s research indicates that Paraquat usage is predominantly concentrated in California’s agricultural counties, impacting mainly Latino communities.

On May 29, the House Agriculture Committee advanced a Farm Bill proposal that includes measures likely to influence pesticide regulation and litigation nationwide.

This bill designates the U.S. Environmental Protection Agency (EPA) as the principal authority on pesticide safety, which could restrict states’ abilities to implement more stringent regulations.

This legislative move is a direct consequence of lobbying efforts by prominent agricultural and chemical corporations.

Companies such as Bayer, along with organizations like CropLife America, support federal oversight of pesticide safety to forestall individual states from establishing tougher regulations.

Their lobbying seeks to establish a consistent regulatory framework that favors their business interests, minimizing the risk of varied state laws or expensive legal challenges related to pesticide damages.

Individuals who have experienced Paraquat exposure and have subsequently developed Parkinson’s Disease or other severe health issues might be eligible to file a Paraquat lawsuit.

Use the chatbot on this page to instantly determine if you qualify for a Paraquat lawsuit.

May 24, 2024

The Paraquat litigation is ongoing, and TorHoerman Law is currently accepting new cases related to Paraquat exposure.

Paraquat, a widely-used herbicide, has been linked to significant health issues, including Parkinson’s disease. It ranks among the most extensively employed weed-control agents globally.

In the United States, farmers apply Paraquat not only for weed management before crop cultivation but also to desiccate crops prior to harvest. Its use spans various agricultural settings including orchards, wheat fields, grazing pastures, cotton fields, and more.

Manufacturers like Syngenta are facing allegations that they did not adequately warn users about the grave health risks of Paraquat, despite longstanding evidence of its potential to cause neurodegenerative diseases.

Paraquat is said to trigger oxidative stress that can damage essential brain cells involved in motor control.

This damage predominantly affects dopamine-producing neurons, which can lead to symptoms of Parkinson’s disease such as tremors and rigidity.

Compensation in the Paraquat litigation could range from $20,000 to over $1,000,000 per claimant, depending on individual cases and the overall progression of the lawsuit.

If you or someone close to you has experienced health issues from Paraquat exposure, possibly developing Parkinson’s Disease or other severe conditions, you might be eligible to participate in a Paraquat lawsuit.

Additionally, you can use the chatbot on this page to instantly determine if you qualify for a Paraquat lawsuit.

May 1, 2024

The Paraquat lawsuit remains ongoing, with a significant number of cases currently pending in multidistrict litigation (MDL).

As per the latest filings from the Judicial Panel on Multidistrict Litigation (JPML), there are 5,590 Paraquat lawsuits awaiting resolution.

Within the past month alone, 225 new lawsuits have been added to the MDL.

Plaintiffs allege that Paraquat, a commonly used herbicide known for its efficacy in controlling resistant weeds and grass, is associated with the development of Parkinson’s disease.

Despite its widespread use, concerns over Paraquat’s neurotoxic properties have led to numerous legal actions against its manufacturer, Syngenta.

Plaintiffs argue that Syngenta failed to adequately warn consumers about the potential risk of Parkinson’s disease.

In California, legislators are advocating for a ban on Paraquat, citing its significant threat to public health and the environment.

They contend that Paraquat is fueling a Parkinson’s epidemic, highlighting the herbicide’s high potential for causing injury and death.

If you or a loved one have been exposed to Paraquat and subsequently developed Parkinson’s disease, you may be entitled to pursue legal action and seek compensation.

We offer free consultations to discuss your options. 

Additionally, our website features a chatbot to help determine your eligibility for filing a Paraquat lawsuit promptly.

April 18, 2024:

The Paraquat Lawsuit continues to unfold.

In a notable turn of events within the Paraquat Products Liability Litigation, U.S. District Judge Nancy J. Rosenstengel has dismissed the initial group of bellwether trials.

This decision, which rejected the plaintiffs’ expert testimony, followed an exhaustive evaluation by Judge Rosenstengel, who oversees the multidistrict litigation that involves allegations linking Paraquat exposure to Parkinson’s disease.

The pivotal cases, having completed the fact and expert discovery stages, relied significantly on the testimony of Cornell University Professor Martin Wells.

Judge Rosenstengel ruled out his testimony, critiquing it for lacking a credible basis and not adhering to the scientific consensus, which refutes the assertion that Paraquat causes Parkinson’s disease.

This decision directly affects numerous plaintiffs who claimed that their exposure to Paraquat, marketed as Gramoxone in the U.S. by Syngenta and previously by Chevron until the 1980s, led to them developing the disease.

Despite being prohibited or restricted in several countries due to its toxicity, Paraquat is still extensively used in the United States.

The lead attorneys for the plaintiffs, representing over 5,000 pending cases, have declared their plan to appeal and to select new cases for trial.

They continue to argue that a significant amount of research backs their claims about the dangers of Paraquat and its health implications.

Both Syngenta and Chevron assert that Paraquat does not cause Parkinson’s disease.

This crucial ruling not only influences the immediate cases but also establishes an important precedent for the remaining claims in this extensive litigation.

Our law firm remains open to new clients for the Paraquat Lawsuit. 

Contact us for a complimentary consultation, or utilize the chatbot on this page to instantly determine if you qualify for the Paraquat Lawsuit

April 4, 2024:

The Paraquat Lawsuit is still active.

California is on the brink of implementing a ban on the herbicide Paraquat, a substance associated with significant health hazards, including Parkinson’s disease, childhood leukemia, and respiratory issues.

A study in central California has shown that residents living within a third of a mile from areas where Paraquat is applied have double the likelihood of developing Parkinson’s disease.

Although over 60 countries, including those in the EU, have prohibited Paraquat, it continues to be extensively used in the U.S., particularly in California, which is a prominent producer of crops like almonds, grapes, and pistachios.

Research by the Environmental Working Group (EWG) indicates that low-income Latino communities in California, heavily exposed to Paraquat on nearby croplands, face substantial health risks. Despite its dangers, the herbicide remains approved for use in the U.S.

Paraquat usage is predominantly concentrated in five counties with high poverty rates and predominantly Latino populations.

Legislation is underway to phase out all Paraquat usage by January 2026.

If you have been exposed to Paraquat and have developed Parkinson’s Disease or other health issues as a result, you might be eligible to participate in the Paraquat Lawsuit.

For a free consultation or use the chatbot on this page to instantly determine if you qualify for the Paraquat Lawsuit.

April 1, 2024:

The litigation concerning Paraquat and its alleged link to Parkinson’s Disease is actively ongoing.

Current records from the Judicial Panel on Multidistrict Litigation (JPML) show a total of 5,365 pending Paraquat Lawsuits, indicating a growth with an addition of nearly fifty cases since the 5,318 reported as of March 1st.

The increment reflects the increasing number of people coming forward to file lawsuits against Paraquat producers, attributing their health complications to exposure to this widely used herbicidal agent.

Paraquat, a chemical employed predominantly for the management of weeds and grass in agricultural settings, has faced scrutiny and legal challenges due to suspected links to severe health risks, including Parkinson’s disease among other conditions.

The plaintiffs in Paraquat Lawsuits typically encompass individuals from the agricultural sector, including workers and farmers, who allege that their health issues stem from working with or around Paraquat.

For individuals or family members affected by Paraquat exposure, TorHoerman Law provides complimentary consultations.

Assessing eligibility for joining in the Paraquat Lawsuit is straightforward with the help of our chatbot on this webpage or by reaching out to us directly for guidance.

The Paraquat Lawsuit is ongoing.

241 new cases were added to the Paraquat MDL in February, as per the latest data from the Judicial Panel for Multidistrict Litigation (JPML).

Initially, on February 1st, the JPML recorded 5,077 cases, which escalated to 5,318 by March 1st. 

This lawsuit centers around the allegations against the use of Paraquat, a herbicide linked to severe health risks, including Parkinson’s disease.

The chemical composition of Paraquat is highly toxic, with a lethal dose as low as 2.5 grams, and it’s associated with increased risks of kidney, heart, and liver failure, as well as lung scarring.

Victims exposed to Paraquat and subsequently diagnosed with Parkinson’s Disease are pursuing legal action against the herbicide’s manufacturers, including Syngenta, Chevron, and Growmark.

These companies face accusations of negligence and failing to adequately inform consumers about the dangers and potential side effects of Paraquat exposure.

Individuals impacted by Parkinson’s disease following Paraquat exposure are encouraged to explore their legal options.

TruLaw Law offers free consultations for those who believe they may be eligible to join the Paraquat Lawsuit, with immediate assistance available through the ChatBot on this page. 

February 19th, 2024:

Chief U.S. District Judge Nancy Rosenstengel has recently appointed nine new plaintiffs, in the Paraquat Dichloride MDL, to replace those in previous claims that have been dismissed due to concerns over their validity.

The litigation currently encompasses over 5,000 claims, consolidated from various federal jurisdictions.

The herbicide is known for its negative neurological effects.

Judge Rosenstengel initially identified six plaintiffs for early trial phases, aiming to set precedent for subsequent cases.

However, challenges such as unconvincing liability theories and evidentiary issues have led to the dismissal of several claims.

Judge Rosenstengel has set a crucial deadline for the completion of dispositions and third-party discovery processes, specfically focusing on distinguishing claims that lack a direct correlation to Paraquat exposure.

Special Master Randi Ellis is tasked with overseeing document requests and third-party depositions.

This includes obtaining subpoenas for retail purchase records and affidavits from supervisors verifying the plaintiffs’ exposure to Paraquat.

In taking a meticulous approach to ensure claim validity, the court has not yet finalized a trial schedule.

February 1, 2024:

The pace of new cases in the Paraquat class action MDL has notably slowed. In January, only 26 new cases were added, following a trend of decreasing additions over the past two years. The total number of pending cases has now reached 5,077.

January 23, 2024:

The Court addressed concerns regarding implausible theories of liability in paraquat exposure cases through Case Management Order No. 18 (CMO 18). The order identified 25 cases with questionable claims and mandated limited discovery to assess their viability. This initiative aims to streamline the docket by addressing cases lacking substantial evidence.

January 4th, 2024:

The Paraquat MDL now encompasses over 5,000 pending cases. However, the past month has seen a notable decrease in case volume, with only 86 new cases added. This marks the lowest monthly case volume in more than two years, and it is the second consecutive month with unusually low activity.

The final week of 2023 proved to be a sluggish period for the Paraquat class action MDL docket. A total of twelve new cases were directly filed within the MDL, and an additional ten cases were transferred in from other districts.

December 1st, 2023:

In the past month, an additional 200 cases have been included in the Paraquat class action MDL, bringing the total number of pending cases to 4,986. This increase indicates that the decline in new case filings observed last month was likely an anomaly.

November 1st, 2023:

Dr. Douglas Weed is seeking to quash a subpoena from the plaintiffs’ attorneys, which is related to his article on paraquat’s potential link to Parkinson’s disease. In his article, titled “Does paraquat cause Parkinson’s disease? A review of reviews,” published in the journal NeuroToxicology in September 2021, he concludes that there is a scientific consensus that paraquat does not cause Parkinson’s disease.

Dr. Weed argues that he has no direct involvement in the case and contends that the extensive document requests are overly burdensome, relate to ongoing research, and exceed the geographical limits defined by Rule 45.

The plaintiffs’ attorneys are interested in understanding how he reached this conclusion, particularly in regard to his funding disclosure, which lacks a specific grant for the article. They have until the end of this week to respond to the motion.

October 17th, 2023:

The Paraquat class action MDL has rapidly expanded in the past two years, with an average of 300 new cases per month and a significant surge of over 1,000 new cases added in July and August. However, only 30 new Paraquat cases were added in September, marking a considerable drop and potentially signaling a changing trend for the MDL.

October 2nd, 2023:

The start of the first Paraquat bellwether case in October has been delayed, casting uncertainty over the future of Paraquat lawsuits. The awaited decision on Daubert challenges, known for their complexity and length, could potentially extend the wait until 2024.

September 27, 2023:

In the Paraquat class action MDL, the final supplement Daubert briefs have been submitted, and a ruling is now pending. Judge Rosenstengel postponed the initial bellwether trial last month to allow more time for reviewing Daubert motions, following a week of hearings.

This extended deliberation by Judge Rosenstengel raises concerns among plaintiffs, as it implies a potential ruling that could exclude plaintiffs’ experts and potentially conclude the MDL.

September 18, 2023:

The Paraquat class action MDL has seen a significant increase with over 1,000 new cases added since Memorial Day. The total number of plaintiffs in the Paraquat MDL has now surpassed 4,700, solidifying its position as one of the largest mass tort cases currently ongoing.

September 6, 2023:

Judge Nancy Rosenstengel has decided to postpone the upcoming Paraquat bellwether trial, which was originally scheduled for October. The reason for this delay is to allow her more time to consider the matters related to the Daubert hearings.

In the context of Multidistrict Litigations (MDLs), a bellwether trial serves as an initial trial that helps establish how other similar cases will be handled. A Daubert hearing involves a dispute between the plaintiff and defendant, overseen by the judge, to determine the admissibility and scope of expert testimony in court.

Judge Rosenstengel has requested both parties to submit additional briefs regarding the Daubert hearings and any issues that have arisen during these proceedings. This additional information will aid her in making informed decisions regarding the trial.

September 1, 2023:

Commencing on August 20, the Daubert proceeding involving an epidemiologist is underway. Dr. Martin Wells, who has previously asserted a notable link between paraquat and the development of Parkinson’s disease, is undergoing evaluation by Judge Nancy Rosenstengel to determine the admissibility of his testimony in court. As of August 22, 2023, a total of 4,554 paraquat-related lawsuits are awaiting resolution in the federal court of Illinois, and the first bellwether trial, initially slated for an earlier date, has been rescheduled to take place in October 2023.

August 1st, 2023

The Judge presiding over the Paraquat MDL is expected to make a ruling on the admissibility of scientific causation evidence connecting Paraquat to Parkinson’s disease.

Both parties have submitted their Daubert motions, and Judge Rosenstengel has scheduled a hearing on the motion for August 21, 2023.

The Judge has mandated that Dr. Martin Wells, the plaintiffs’ key expert witness, must appear at the hearing and provide testimony crucial to the decision on admissibility.

Following the hearing, Judge Rosenstengel has granted the parties the opportunity to submit closing briefs by September 8, 2023.

July 1st, 2023:

Defendants Syngenta and Chevron have identified 611 claims in the MDL that they consider questionable.

The defendants argue that some claims lack sufficient evidence and were filed based on targeted advertising campaigns and lead generators.

It is unlikely that all 611 claims are non-viable, and eventually, the issue of whether Paraquat causes Parkinson’s disease will be decided by a jury.

The first bellwether trial is set to commence in October, 2023.

July 18, 2023

A total of 223 new Paraquat lawsuits were transferred into the class action MDL, raising the overall pending case count to 4,306.

This figure is slightly lower than the average number of new cases seen in the past 16 months, hinting at a potential delay in new filings for this litigation.

June 16th, 2023:

The Paraquat class action MDL has recently seen an addition of 353 new plaintiffs, raising the total number of claims pending in the MDL to 4,083.

Since the beginning of 2023, 1,731 new Paraquat cases have been included in the MDL.

June 12th, 2023:

Chevron and Syngenta AG have filed for summary judgment in the MDL, contending that the plaintiffs’ claims linking Paraquat to Parkinson’s disease lack scientific evidence.

They argue that no peer-reviewed studies have confirmed this connection, challenging the validity of the claims.

Although it is unlikely, approximately 3,700 claims could be dismissed if the motion is passed.

May 1st, 2023:

The court denies the motion filed by Syngenta and Chevron to strike Martin Wells’ rebuttal expert report in the Paraquat class action MDL.

The report is deemed to adequately address the opinions and criticisms of the defendants’ expert.

The order instructs any further objections from the defendants to be raised through a Daubert motion.

Additionally, Judge Rosenstengel orders all parties to propose a Case Management Order by April 19, 2023, specifying agreed-upon deadlines for submitting summary judgment and Daubert motions, as well as any guidelines or limitations for these motions.

May 10th, 2023:

Defense counsel accuses plaintiffs’ lawyers in the Paraquat class action MDL of filing pleadings on behalf of deceased clients.

This occurrence, while undesirable, does not significantly prejudice the defendants.

A request is made for the court to address this issue

May 15th, 2023:

The Paraquat class action MDL experiences a surge in new lawsuits, with over 500 Paraquat Parkinson’s disease cases added in the past month.

This is the highest monthly total in over a year, following consecutive months of over 200 new cases.

Since the beginning of the year, the MDL has seen 1,300 new cases added.

If this pace continues, the number of pending cases is projected to surpass 5,000 by year-end.

There are currently over 2,000 Paraquat lawsuits pending in the Paraquat MDL in Illinois, as well as 264 cases in the Pennsylvania state court system.

The Judge in the Pennsylvania Paraquat class action has ruled that new plaintiffs can use a Short Form Complaint when filing their case.

March 1st, 2023:

The defense team in the Paraquat class action MDL filed a motion to strike a supplemental expert report submitted by plaintiff expert David Mortensen.

The report was submitted after the deadline for expert reports and sought to clarify certain issues raised during Mortensen’s deposition.

The Court is expected to rule on the motion soon.

March 5th, 2023:

Syngenta produced documents indicating that the company may have known about the potential health risks of exposure to Paraquat as far back as the 1970s and was aware of the link between Paraquat and Parkinson’s disease by 2001.

March 16th, 2023:

277 new plaintiffs joined the Paraquat class action MDL in the last month, bringing the total number of pending cases up to 2,998.

This marks the second month in a row that the Paraquat MDL has posted an above-average volume of new case filings.

With the first bellwether test trial coming up in the summer, both sides are starting to battle over what evidence will be permitted at trial.